Welltower (NYSE:WELL) Issues Quarterly Earnings Results, Beats Expectations By $1.03 EPS

Key Points

• Welltower reported quarterly EPS of $1.67, exceeding analysts’ consensus estimate of $0.64 by $1.03. The healthcare REIT posted a 12.15% net margin and 3.56% return on equity.
• Shares rose 1.2% to $240.11, while analysts maintained a generally positive outlook: Welltower has a “Moderate Buy” consensus rating and an average price target of $255.86.
• Director Andrew Gundlach purchased 5,000 shares for approximately $1.21 million, increasing his ownership by 20%; insiders collectively own 0.37% of the company.

Welltower (NYSE:WELL - Get Free Report) announced its quarterly earnings results on Monday. The real estate investment trust reported $1.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.64 by $1.03, Zacks reports. Welltower had a return on equity of 3.56% and a net margin of 12.15%.

Welltower Trading Up 1.2%

WELL traded up $2.79 during mid-day trading on Monday, hitting $240.11. The stock had a trading volume of 2,280,197 shares, compared to its average volume of 3,090,940. Welltower has a 1-year low of $174.91 and a 1-year high of $255.20. The firm has a market capitalization of $173.06 billion, a price-to-earnings ratio of 110.14, a price-to-earnings-growth ratio of 1.15 and a beta of 0.75. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.16 and a quick ratio of 3.16. The stock's fifty day simple moving average is $233.88 and its 200-day simple moving average is $225.54.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on WELL shares. Robert W. Baird upped their price target on Welltower from $226.00 to $233.00 and gave the company a "neutral" rating in a report on Wednesday, August 12th. Deutsche Bank Aktiengesellschaft raised their price objective on Welltower from $215.00 to $265.00 and gave the company a "buy" rating in a research note on Wednesday, July 1st. Evercore reissued an "outperform" rating and issued a $256.00 price objective (down from $260.00) on shares of Welltower in a research report on Monday, September 21st. Mizuho raised their price objective on Welltower from $239.00 to $260.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 22nd. Finally, Scotiabank lifted their price objective on Welltower from $244.00 to $251.00 and gave the company an "outperform" rating in a report on Wednesday, September 2nd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Welltower currently has an average rating of "Moderate Buy" and a consensus price target of $255.86.

Insider Transactions at Welltower

In related news, Director Andrew Gundlach bought 5,000 shares of Welltower stock in a transaction that occurred on Wednesday, August 26th. The stock was purchased at an average cost of $242.06 per share, with a total value of $1,210,300.00. Following the purchase, the director owned 30,000 shares in the company, valued at approximately $7,261,800. This trade represents a 20.00% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Purchased indirectly through two trusts. The transaction was executed in multiple trades at prices ranging from $241.59 to $242.59. The reported $242.06 price is the weighted-average purchase price. Insiders own 0.37% of the company's stock.

Welltower Company Profile

Welltower Inc NYSE: WELL is a healthcare-focused real estate investment trust that owns, develops, and manages properties used to provide healthcare and related services. Its portfolio is centered on senior housing communities, outpatient medical facilities, and post-acute care properties, including assets operated by healthcare providers and senior living companies.

The company's senior housing investments support independent living, assisted living, and memory care services. Its outpatient medical properties accommodate physicians, clinics, and other healthcare providers, while its broader healthcare real estate portfolio is designed to serve demand for care delivered outside traditional hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.